Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study

Life Sciences

Volumn 58, Issue 20, 1996, Pages 1777-1784

  Dorr, Robert T ^a,b   Lines, Ruskin ^c   Levine, Norman ^c   Brooks, Christine ^b   Xiang, Li ^c   Hruby, Victor J ^c   Hadley, Mac E ^c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

melanotropins; pigmentation; tanning

Indexed keywords

ALPHA INTERMEDIN DERIVATIVE; CYCLOPEPTIDE; HEPTAPEPTIDE; MELANOTAN 2; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONFORMATION; DRUG STRUCTURE; FATIGUE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; PENIS ERECTION; PHASE 1 CLINICAL TRIAL; SINGLE BLIND PROCEDURE; SKIN PIGMENTATION; SOMNOLENCE; SUBCUTANEOUS DRUG ADMINISTRATION; VOLUNTEER; YAWNING;

POROMITRA OSCITANS;

EID: 0029980737     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00160-9     Document Type: Article

References (25)

1. M.E. HADLEY (ed.) Endocrinology, 3rd Edition, Chapter 8 p. 179-207, Prentice-Hall, Englewood Cliffs, New Jersey (1992).
2. J.T. BAGNARA, and M.E. HADLEY, Comparative Physiology of Animal Pigmentation, H.A. Bern (ed.), p. 6-129, Prentice-Hall, Englewood Cliffs, New Jersey, (1973).
3. T.K. SAWYER, V.J. HRUBY, B.T. WILKES, M.T. DRAELOS, M.E. HADLEY, and M. BERGSCHNEIDER, J. Med. Chem. 25 1022-1027 (1982).
4. A.M.L. CASTRUCCI, M.E. HADLEY, T.K. SAWYER and V.J. HRUBY, Comp. Biochem. Physiol. 78 519-524 (1984).
5. R.T. DORR, B.V. DAWSON, M.E. HADLEY, N. LEVINE and V.J. HRUBY, Invest. New Drugs 6 251-258 (1988).
6. B.V. DAWSON, C.A. FORD, H. HOLLOWAY, R.T. DORR and P. JOHNSON, Toxicol., 77 91-101 (1993).
7. N. LEVINE, S.N. SHEFTEL, T. EYTAN, R.T. DORR, M.E. HADLEY, J.C. WEINRACH, G.A. ERTL, K. TOTH, D.L. MCGEE, and V.J. HRUBY, J. Amer. Med. Assoc., 266 2730-2736 (1991).
8. W.L. CODY, M.E. HADLEY, and V.J. HRUBY, The Melanotropic Peptides, Volume III, M.E. Hadley (ed.), p. 75-92, CRC Press, Boca Raton, Florida (1988).
9. F. AL-OBEIDI, M.E. HADLEY, B.M. PETTITT, and V.J. HRUBY, J. Am. Chem. Soc., 111 3413-3416 (1989).
10. F. AL-OBEIDI, A.M.L. CASTRUCCI, M.E. HADLEY and V.J. HRUBY, J. Med. Chem., 32 2555-2561 (1989).
11. M.E. HADLEY, M.M. MARWAN, F. AL-OBEIDI, V.J. HRUBY and A.M.L. CASTRUCCI, Pigment Cell Res., 2 478-484 (1989).
12. S.O. UGWU, J. BLANCHARD, L.D. NGUYEN, M.E. HADLEY, and R.T. DORR, Biopharm. Drug Disp., 15 383-390 (1994).
13. P.D. JOHNSON, B.V. DAWSON, R.T. DORR, M.E. HADLEY, N. LEVINE, and V.J. HRUBY, Am. J. Vet. Res., 55 1593-1596 (1994).
14. T.B. FITZPATRICK, Arch. Dermatol., 124 869-871 (1988).
15. A.B. MILLER, B. HOOGSTRATEN, M. STAQUET, and A. WINKLER, Cancer, 47 207-214 (1981).
16. J.C. SEITZ and C.G. Whitmore, Dermatologica, 177 70-75 (1988).
17. S.B. PORGES, K.H. KAIDBEY, and G.L. GROVE, Photodermatol., 5 197-200 (1988).
18. W. WESTERHOF, B.A.A.M. VAN HASSELT, and A. KAMMEIJER, Photodermatol., 3 310-314 (1986).
19. G. Szabo, Br. Med. J., 1 1016-1017 (1954).
20. A.B. LERNER, and J.S. MCGUIRE, Nature, 189 176-179 (1961).
21. A.B. LERNER, and J.S. MCGUIRE, N. Engl. J. Med., 270 539-546 (1964).
22. E.-L. LAN, S.O. UGWU, J. BLANCHARD, X. FANG, V.J. HRUBY, and S. SHARMA, J. Pharm. Sci., 83 1081-1084 (1994).
23. A. BERTOLINI, and G.L. GESSA, J., Endocrinol. Invest., 4 241-259 (1984).
24. I. GANTZ, K. YOSHITAKA, T. TASHIRO, Y. SHIMOTO, H. MIWA, G. MUNZERT, S.J. WATSON, J. DEL VALLE, and T. YAMADA, J. Biol. Chem., 268 8246-8250 (1993).
25. K.G. MOUNTJOY, L.S. ROBBINS, M.T. MORTRUD, and R.D. CONE, Science, 257 1248-1251 (1992).